• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • WORLD EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • WORLD EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    CVS Health Executive Vice President and CFO interviewed by Advisor Access

    Bryan Mc Govern
    Feb. 28, 2017 10:52AM PST
    Pharmaceutical Investing

    CVS Health (NYSE:CVS) Dave Denton, Executive Vice President and CFO of the company, was interviewed by Advisor Access on all aspects of the company and its focus.

    CVS Health (NYSE:CVS) Dave Denton, Executive Vice President and CFO of the company, was interviewed by Advisor Access on all aspects of the company and its focus.
    As quoted in the press release:

    Advisor Access: CVS Health has been focused on the theme of driving more affordable, accessible, and effective care. Can you talk about how you are executing on each of those objectives?
    Dave Denton: As the healthcare market continues to evolve, healthcare stakeholders are placing increased emphasis on making care more affordable, accessible, and effective. We believe no other company has the full suite of assets to deliver on each of these objectives. We’ve built the capabilities to integrate pharmacy care from the payer to the provider to the patient…
    AA: Drug pricing has been in the news repeatedly over the last year. How is CVS approaching this issue?
    DD: One of the biggest and most complex challenges facing the healthcare system is the increasing cost of medications. Price inflation on established branded products, as well as new specialty products coming to market at elevated price points, are creating new challenges for plan sponsors and patients alike…
    Read the complete answers to these questions and the full interview with CVS, HERE.
    About Advisor Access:
    Advisor Access LLC brings compelling investment ideas to investors in the form of in-depth interviews with company management and the latest fact sheets and corporate presentations.

    Click here for full press release.

    drug pricingpharmaceutical investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Medicine capsule showing active ingredients.

    5 Biggest Pharma Stocks

    Scientist with petri dish.

    Pharma Market Forecast: Top Trends for Pharma in 2025

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    Invion Limited

    IVX:AU

    Cardiol Therapeutics

    CRDL:CA
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×